Our infection prevention
solutions reduce the risk of
healthcare associated infections,
increase patient safety and
reduce the use of antibiotics.
Bactiguard Holding AB (publ) published the interim report for the third quarter on Thursday November 5, 2020 at 08:00 CET.
In connection with this, a audiocast for investors, analysts and media was held at 11:00 CET on November 5, where CEO Cecilia Edström and CFO Gabriella Björknert presented the interim report and answered questions.
Hydrocyn® aqua is a non-alcoholic disinfectant solution for, for example, skin and surfaces. The active substance hypochlorous acid (HOCl) is a part of the human immune system. Hydrocyn® aqua kills:
Hydrocyn® aqua is proven effective against the SARS-CoV-2 virus that causes COVID-19 and against previous strains of coronavirus.
The Bactiguard technology reduces microbial adhesion to the surface of medical devices, which decreases the risk of biofilm formation leading to infection.
The BIP Foley TempSensor is an indwelling urinary catheter which combines continuous temperature monitoring with Bactiguard’s infection prevention technology.
Hydrocyn® aqua is a non-alcoholic disinfectant solution for, for example, skin and surfaces, proven effective against the new coronavirus SARS-CoV-2.
Bactiguard Holding AB (publ) published the interim report for the third quarter on Thursday November 5, 2020 at 08:00 CET.
